Intra-Cellular Therapies to Present at the Cantor Virtual Global Healthcare Conference
September 14 2020 - 8:00AM
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical
company focused on the development and commercialization of
therapeutics for central nervous system (CNS) disorders, today
announced that Sharon Mates, Ph.D., Chief Executive Officer and
Chairman, is scheduled to participate in a fireside chat at
the Cantor Virtual Global Healthcare Conference on Tuesday,
September 15, 2020 at 10:00 am ET.
The live and archived webcast can be accessed under "Events
& Presentations" in the Investor Relations section of the
Company's website at www.intracellulartherapies.com. Please log in
approximately 5-10 minutes prior to the event to register and to
download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded
on Nobel prize-winning research that allows us to understand how
therapies affect the inner-workings of cells in the body. The
company leverages this intracellular approach to develop innovative
treatments for people living with complex psychiatric and
neurologic diseases.
Contact
Intra-Cellular Therapies, Inc.Juan Sanchez, M.D.Vice President,
Corporate Communications and Investor Relations646-440-9333
Burns McClellan, Inc. Lisa Burns jgrimaldi@burnsmc.com
212-213-0006
Media Inquiries:
Ana FullmerCorporate Media Relations
W20wcgafullmer@wcgworld.com202-507-0130
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Apr 2023 to Apr 2024